Adding cancer antigen 125 screening to gray scale sonography for predicting specific diagnosis of benign adnexal masses in premenopausal women: Is it worthwhile?

Journal of Ultrasound in Medicine

Volumn 30, Issue 10, 2011, Pages 1381-1386

  Alcázar, Juan Luis ^a   Guerriero, Stefano ^b   Mínguez, José Ángel ^a   Ajossa, Silvia ^b   Paoletti, Anna Maria ^b   Ruiz Zambrana, Álvaro ^a   Jurado, Matías ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Adnexal masses; Cancer antigen 125; Premenopause; Sonography

Indexed keywords

ANTIGENS; BODY FLUIDS; DISEASES; PATTERN RECOGNITION; TUMORS; ULTRASONIC IMAGING; ULTRASONOGRAPHY;

ADNEXAL MASS; CANCER ANTIGEN 125; CONFIDENCE INTERVAL; GRAY SCALE SONOGRAPHY; PREMENOPAUSAL WOMEN; PREMENOPAUSE; SPECIFIC DIAGNOSIS; TRANSVAGINAL SONOGRAPHY;

DIAGNOSIS;

CA 125 ANTIGEN; TUMOR MARKER;

ADNEXA DISEASE; ADOLESCENT; ADULT; ARTICLE; AUTOMATED PATTERN RECOGNITION; BLOOD; CHI SQUARE DISTRIBUTION; CONFIDENCE INTERVAL; ECHOGRAPHY; FEMALE; HUMAN; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PREDICTIVE VALUE; PREMENOPAUSE; RETROSPECTIVE STUDY; STATISTICAL MODEL; VAGINA;

ADNEXAL DISEASES; ADOLESCENT; ADULT; CA-125 ANTIGEN; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; VAGINA;

EID: 80053546624     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2011.30.10.1381     Document Type: Article

References (22)

1. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary: FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(suppl 1):S161-S192.
2. American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of adnexal masses. Obstet Gynecol 2007;110:201-214.
3. Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol 2009;142:99-105.
4. Van Calster B, Timmerman D, Bourne T, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 2007;99:1706-1714. (Pubitemid 351767215)
5. Guerriero S, Alcázar JL, Coccia ME, et al. Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med 2002;21:1105-1111.
6. Sokalska A, Timmerman D, Testa AC, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 2009;34:462-470.
7. Valentin L, Jurkovic D, Van Calster B, et al. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol 2009;34:345-354
8. Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice. J Clin Pathol 2005;58:308-312. (Pubitemid 40380329)
9. Guerriero S, Ajossa S, Gerada M, et al. Transvaginal ultrasonography in the diagnosis of extrauterine pelvic diseases. Expert Rev Obstet Gynecol 2008;3:731-752.
10. Valentin L. Use of morphology to characterize and manage common adnexal masses. Best Pract Res Clin Obstet Gynaecol 2004;18:71-89. (Pubitemid 38324637)
11. Guerriero S, Alcázar JL, Pascual MA, et al. Diagnosis of the most frequent benign ovarian cysts: is ultrasonography accurate and reproducible? J Womens Health 2009;18:519-527.
12. Scully RE, Sobin LH. World Health Organization Histological Classification of Ovarian Tumors. Berlin, Germany: Springer-Verlag; 1999.
13. Biggerstaff BJ. Comparing diagnostic test: a simple graphic using likelihood ratios. Stat Med 2000;19:649-663. (Pubitemid 30143558)
14. Mais V, Ajossa S, Piras B, Marongiu D, Guerriero S, Melis GB. Treatment of nonendometriotic benign adnexal cysts: a randomized comparison of laparoscopy and laparotomy. Obstet Gynecol 1995;86:770-774
15. Mais V, Ajossa S, Mallarini G, Guerriero S, Oggiano MP, Melis GB. No recurrence of mature ovarian teratomas after laparoscopic cystectomy. BJOG 2003;110:624-626 (Pubitemid 36694222)
16. Gadducci A, Baicchi U, Marrai R, Ferdeghini M, Bianchi R, Facchini V. Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses. Gynecol Oncol 1996;60:197-202. (Pubitemid 26058762)
17. Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature Hum Reprod 1989;4:1-12. (Pubitemid 19069900)
18. Paavonen J, Miettinen A, Heinonen PK, et al. Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1989;96:574-579. (Pubitemid 19146814)
19. Alcazar JL, Guerriero S, Laparte C, Ajossa S, Ruiz-Zambrana A, Melis GB. Diagnostic performance of transvaginal gray-scale ultrasound for specific diagnosis of benign ovarian cysts in relation to menopausal status. Maturitas 2011;68:182-188.
20. Van Holsbeke C, Daemen A, Yazbek J, et al. Ultrasound experience substantially impacts on diagnostic performance and confidence when adnexal masses are classified using pattern recognition. Gynecol Obstet Invest 2009;69:160-168.
21. Sevinc A, Sari R, Camci C, Buyukberber S. A secondary interpretation is needed on serum CA 125 levels in case of serosal involvement. J R Soc Promot Health 2000;120:268-270. (Pubitemid 32058569)
22. Kim MY, Rha SE, Oh SN, et al. MR imaging findings of hydrosalpinx: a comprehensive review. Radiographics 2009;29:495-507.